Literature DB >> 6611092

Patterns of drug use from adolescence to young adulthood: I. Periods of risk for initiation, continued use, and discontinuation.

D B Kandel, J A Logan.   

Abstract

Patterns of initiation, continued use, and decline in drug use are described on the basis of detailed drug histories in a longitudinal cohort representative of former New York State adolescents. In this cohort, the period of major risk for initiation to cigarettes, alcohol, and marijuana, is completed for the most part by age 20, and to illicit drugs other than cocaine by age 21. Those who have not experimented with any of these substances by that age are unlikely to do so thereafter. Initiation into prescribed psychoactive drugs occurs at a later age than for the licit and illicit drugs and continues through the age period covered by the survey. A potential maturational trend in marijuana use in this cohort is apparent with a decline beginning approximately at age 22.5 for most usage patterns. The periods of highest marijuana and alcohol usage decline beginning at ages 20-21 and contrast sharply with cigarettes which exhibit climbing rates of highest use through the end of the surveillance period (age 25). Overall patterns are similar for men and women, with men initiating all drugs at higher rates than women, except for prescribed psychoactives .

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611092      PMCID: PMC1651682          DOI: 10.2105/ajph.74.7.660

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  1 in total

1.  The reliability and validity of interview data obtained from 59 narcotic drug addicts.

Authors:  J C Ball
Journal:  AJS       Date:  1967-05
  1 in total
  123 in total

1.  Efficacy of a preventive intervention for youths living with HIV.

Authors:  M J Rotheram-Borus; M B Lee; D A Murphy; D Futterman; N Duan; J M Birnbaum; M Lightfoot
Journal:  Am J Public Health       Date:  2001-03       Impact factor: 9.308

2.  Preventive intervention effects on developmental progression in drug use: structural equation modeling analyses using longitudinal data.

Authors:  L M Scheier; G J Botvin; K W Griffin
Journal:  Prev Sci       Date:  2001-06

3.  Substance use among adults 35 years of age: prevalence, adulthood predictors, and impact of adolescent substance use.

Authors:  Alicia C Merline; Patrick M O'Malley; John E Schulenberg; Jerald G Bachman; Lloyd D Johnston
Journal:  Am J Public Health       Date:  2004-01       Impact factor: 9.308

4.  On a roll: the process of initiation and cessation of problem gambling among adolescents.

Authors:  C C DiClemente; M Story; K Murray
Journal:  J Gambl Stud       Date:  2000

5.  Use of HAART among young people living with HIV.

Authors:  W Scott Comulada; Dallas T Swendeman; Mary Jane Rotheram-Borus; Kathy M Mattes; Robert E Weiss
Journal:  Am J Health Behav       Date:  2003 Jul-Aug

6.  Drug abuse in children and adolescents: an update.

Authors:  H Swadi
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

7.  Indices of lifetime polydrug use among adolescents.

Authors:  Carl D Sneed; Donald E Morisky; Mary Jane Rotheram-Borus; Sung-Jae Lee; Vicki J Ebin
Journal:  J Adolesc       Date:  2004-06

8.  Racial/ethnic differences in adolescent substance use: mediation by individual, family, and school factors.

Authors:  Regina A Shih; Jeremy N V Miles; Joan S Tucker; Annie J Zhou; Elizabeth J D'Amico
Journal:  J Stud Alcohol Drugs       Date:  2010-09       Impact factor: 2.582

9.  Smoking cessation advantage among adult initiators: does it apply to black women?

Authors:  Azure B Thompson; Joyce Moon-Howard; Peter A Messeri
Journal:  Nicotine Tob Res       Date:  2010-11-15       Impact factor: 4.244

10.  Correlates of concurrent energy drink and alcohol use among socially active adults.

Authors:  Brooke E Wells; Brian C Kelly; Mark Pawson; Amy Leclair; Jeffrey T Parsons; Sarit A Golub
Journal:  Am J Drug Alcohol Abuse       Date:  2012-10-03       Impact factor: 3.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.